INTERNATIONAL PATENT: RUIDAX GENE TECHNOLOGY CO., LTD., 杭州睿导基因科技有限公司 FILES APPLICATION FOR "ONCOLYTIC VIRUS-T CELL CHIMERA FOR CANCER THERAPY AND USE THEREOF"

GENEVA, July 28 -- RUIDAX GENE TECHNOLOGY CO., LTD. (Room 562, Building 2, No. 98 Avenue, No.19 Baiyang Street, Qiantang New DistrictHangzhou, Zhejiang 310018), 杭州睿导基因科技有限公司 (中国浙江省杭州市钱塘新区白杨街道19号大街98号2幢562室) filed a patent application (PCT/CN2025/072088) for "ONCOLYTIC VIRUS-T CELL CHIMERA FOR CANCER THERAPY AND USE THEREOF" on Jan 13, 2025. With publication no. WO/2025/152901, the details related to the patent application was published on Jul 24, 2025.

Notably, the patent application was submitted under th...